Single-enantiomer drugs represent an increasingly large share of new chemical entities, leading to approaches in asymmetric synthesis.
Nicholas B. Johnson
Advertisement
Nicholas B. Johnson, PhD, is a business development and marketing manager at Chirotech Technology Ltd.
Articles by Nicholas B. Johnson
Advertisement
Latest Updated Articles
Manufacture of Asymmetric Hydrogenation CatalystsPublished: October 4th 2007 | Updated:
Advertisement
Advertisement
